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Buccal cells were collected from 29 participants, by use of mouthwash rinses, and were split into equal aliquots, with
one aliquot irradiated by electron-beam (E-beam) irradiation equivalent to the sterilizing dosage used by the U.S.
Postal Service and the other left untreated. Aliquots were extracted and tested for DNA yields (e.g., TaqMan assay
for quantifying human genomic DNA), genomic integrity, and ampliﬁcation-based analysis of genetic variants (e.g.,
single-nucleotide polymorphisms [SNPs] and single tandem repeats [STRs]). Irradiated aliquots had lower median
DNA yields (3.7 mg/aliquot) than untreated aliquots (7.6 mg/aliquot) ( ) and were more likely to have smallerP ! .0005
maximum DNA fragment size, on the basis of genomic integrity gels, than untreated aliquots ( ). IrradiatedP ! .0005
aliquots showed poorer PCR ampliﬁcation of a 989-bp b-globin target (97% for weak ampliﬁcation and 3% for
no ampliﬁcation) than untreated aliquots (7% for weak ampliﬁcation and 0% for no ampliﬁcation) ( ),P ! .0005
but 536-bp and 268-bp b-globin targets were ampliﬁed from all aliquots. There was no detectable irradiation effect
on SNP assays, but there was a signiﬁcant trend for decreased detection of longer STRs ( ) in irradiatedPp .01
versus untreated aliquots. We conclude that E-beam irradiation reduced the yield and quality of buccal-cell spec-
imens, and, although irradiated buccal-cell specimens may retain sufﬁcient DNA integrity for some ampliﬁed analyses
of many common genomic targets, assays that target longer DNA fragments (1989 bp) or require whole-genome
ampliﬁcation may be compromised.
Self-collected buccal-cell specimens are a relatively inex-
pensive, noninvasive collection method of genomic DNA
for molecular epidemiologic studies (Lench et al. 1988;
Lum et al. 1998; Walker et al. 1999; Garcia-Closas et
al. 2001; Le Marchand et al. 2001). Specimens can be
collected by a variety of methods, including a simple
mouthwash rinse and expectoration into a collection vial
that can be sent via mail. Several large U.S. epidemi-
ologic studies—including The Prostate, Lung, Colorectal
andOvarianCancer Screening Trial (Gohagan et al. 2000)
and Agricultural Health Study (Mage et al. 2000)—
have chosen to use self-collected buccal cells to facilitate
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sample collection for genomic DNA. However, the use
of electron-beam (E-beam) irradiation has been recently
implemented by the U.S. Postal Service (USPS) to “ster-
ilize” mail (via cleavage of microbe DNA) as a protective
measure against terrorism with biological agents. (The
USPS irradiation plan is currently limited to mail re-
ceived at ZIP postal codes inWashington, DC, that begin
202–205. We are not aware of immediate plans to ex-
pand the irradiation treatment to other ZIP codes.) The
potential effects of decontaminating radiation on DNA
yields and quality from E-beam–exposed buccal cells sent
through the U.S. Mail are largely unknown.
To address this issue, buccal-cell specimens were col-
lected by expectoration of a mouthwash rinse (Scope
[Procter & Gamble]) into a collection vial from 32 con-
senting volunteers, according to a National Cancer In-
stitute (NCI) institutional review board–approved pro-
tocol (Garcia-Closas et al. 2001). Specimens were split
into equal aliquots and were assigned unique identiﬁers.
One aliquot remained untreated. The other aliquot for
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Figure 1 Color of Scope before (left) and after (right) sterilizing E-beam irradiation
Figure 2 Results of 989-bp b-globin fragment PCR ampliﬁcation of DNA extracted from aliquots of buccal cells. The arrow indicates
the 989-bp fragment. Lanes 3–12 and 14 (3,4,8, and 10–12 are E-beam irradiated, and 5–7, 9, and 14 are untreated) are test specimens, lanes
13 and 15 are blank controls, lane 2 is a positive ampliﬁcation control (K562 cell DNA), and lanes 1 and 16 are molecular size standards.
Lanes 5, 6, 9, and 14 were rated as “positive,” lanes 3, 4, 7, 8, 10, and 11 were rated as “weak positive,” and lanes 12, 13, and 15 were rated
as “negative.”
29 pairs (3 were shipped but remained untreated, for use
as shipping controls) was exposed to E-beam irradiation
(Titan Scan Technologies) by use of a protocol that simu-
lated potential exposure (56 kilograys [KGy]) through
the USPS (Hanson 2002). Aliquots were placed on a con-
veyor belt and exposed twice to 10 million electron–
volt radiation, which resulted in a total dose in the range
of 70–97 KGy. Specimens were returned to the NCI bio-
repository, cells were pelleted by centrifugation, and,
after the supernatant was decanted, the cell pellet was
stored at 70 C to 80 C until DNA extraction.
Frozen buccal-cell pellets were suspended in Tris-EDTA
buffer, and genomic DNA was extracted using phenol-
chloroform (Lum et al. 1998). Total-DNA yields were
quantiﬁed by spectrophotometry at 260-nm and 280-nm
wavelengths and the PicoGreen assay (Molecular Probes)
(Hopwood et al. 1997). Human-speciﬁc genomic DNA
was quantiﬁed using a TaqMan assay that ampliﬁes a
119-bp region of the human DNA BRCA1 gene (Haque
et al., in press). The integrity of genomic DNA was as-
sessed using gel electrophoresis on 0.4% agarose gels
stained with ethidium bromide. Electrophoreticmigration
of specimen DNA was compared with known molecular
size markers (Ready-Load l DNA/HindIII Fragments
[Invitrogen]) and were rated for the maximum fragment
size as “no visible DNA,” “!564 bp,” “!6,557 bp,”
“!23,130 bp,” or “23,130 bp” (Garcia-Closas et al.
2001). PCR ampliﬁcations of 268-bp, 536-bp, and 989-
bp b-globin fragments were performed as described else-
where, with 15–20 ng of extracted DNA per reaction
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Table 1
Summary of DNA Yields, DNA Integrity Measurement, and Outcomes of PCR
Ampliﬁcation of b-Globin Fragments of Lengths 989 bp, 536 bp, and 268 bp
METHOD
RESULTS FOR PAIRED ALIQUOTS
( )np 29
PaUntreated Irradiated
DNA yields, medianb:
Spectrophotometric (260 nm) 12.3 mg 5.9 mg .002
PicoGreen 8.9 mg 3.9 mg .01
TaqMan 7.6 mg 3.7 mg !.0005
Genomic integrity (maximum size)c:
23,130 bp 93.1% .0%
!23,130 bp 6.9% 31.0%
!.0005
!6,557 bp .0% 65.5%
!564 bp .0% 3.5%
PCR Ampliﬁcation of a 989-bp b-globin:
Positive 93% 0%
Weak positive 7% 97% !.0005
Negative 0% 3%
PCR Ampliﬁcation of a 536-bp b-globin:
Positive 100% 100%
Weak positive 0% 0% 1.0
Negative 0% 0%
PCR Ampliﬁcation of a 268-bp b-globin:
Positive 100% 100%
Weak positive 0% 0% 1.0
Negative 0% 0%
a Wilcoxon matched-pair sign-rank test (continuous) and Pearson x2 test (categorical).
b Yield per aliquot. Each aliquot represents one-half of the whole mouthwash specimen.
c Electrophoretic migration of specimen DNA was compared with knownmolecular
size markers (Ready-Load l DNA/HindIII Fragments [Invitrogen]) and rated for the max-
imum fragment size as “no visible DNA,” “!564 bp,” “!6,557 bp,” “!23,130 bp,” or
“23,130 bp.”
(Greer et al. 1994; Lum et al. 1998; Garcia-Closas et al.
2001). Ampliﬁed products were separated on 4% agarose
gels for the 268-bp and 536-bp fragments and 3% gels
for the 989-bp fragment; a lane with a positive ampli-
ﬁcation control (K562 DNA [Promega]) and lanes with
a 100-bp DNA ladder (Invitrogen) were run on each gel.
Masked to the treatment status, results were evaluated
independently by two raters as “negative” (no band ob-
served), “weak positive” (a band was observed at the
correct molecular size, but band intensity !25% of the
K562 band), or “positive” (a band was observed at the
correct molecular size, but band intensity 25% of the
K562 band). Discrepancies between “positive” and
“weak positive” ratings were, by default, called “posi-
tive.” Discrepancies between “weak positive” and “nega-
tive” ratings were adjudicated by running the ampliﬁed
product on a polyacrylamide gel and staining the gel with
silver nitrate stain. A sample was called “weak positive”
if the presence of a band at the correct molecular size
was detected; otherwise, it was called “negative.” Differ-
ences in continuous measurements (DNA yield and purity
[the ratio of the spectrophometric readings at 260 nm and
280 nm]) and categorical measurements (genomic integ-
rity and PCR ampliﬁcation) between irradiated and un-
treated aliquots were tested for signiﬁcance ( ; two-P ! .05
sided) by use of the Wilcoxon matched-pair sign-rank test
and the Pearson x2 test, respectively.
Sixteen STRs and 10 SNPs were measured for each pair
of aliquots, masked to the irradiation status. Speciﬁcally,
0.25 ng of extracted DNA were tested for the following
16 STR loci: D8S1179, D21S11, D7S820, CSF11PO,
D3S1358, TH01, D13S317, S16S539, D2S1338,
D19S433, vWA, TPOX, S18S51, D5S818, AMELI, and
FGA. The AmpFLSTRR IdentiﬁlerT PCR Ampliﬁcation
Kit (Applied Biosystems [ABI]) was used per manufac-
turer’s instructions and included the 13 core STR loci
standardized under the Federal Bureau of Investigation’s
Combined DNA Index System (ABI) (Buse et al. 2003).
Differences between irradiated and untreated aliquots for
detection of any single STR were evaluated using sym-
metry x2 tests. A linear regression model was used to
evaluate the effects of the predicted maximum size of
the STRs, irradiation (yes or no), and their interaction
on the failure rate of these measurements. Ten frequent
and commonly tested National Cancer Institute cancer-
related SNPs (BRCA1-02, BRCA2-01, MGMT-04,
MPO-02, MTHFR-01, NAT1-20, NAT2-01, SOD2-01,
XRCC1-01, and XRCC3-01) were assayed in duplicate,
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Figure 3 The effect of E-beam irradiation on the failure rate of detection of STRs as a function of size of the STR for irradiated () versus
untreated () aliquots. Fragment size ( ), irradiation status ( ), and the interaction of fragment size and irradiation status (P ! .0005 Pp .08 Pp
) were associated with increased measurement failure..01
with 5 ng of extracted DNA by TaqMan (ABI). The du-
plicate results were combined and grouped as “measured”
(“homozygous” or “heterozygous” for either test) or “un-
measured” (“undetermined” or “not ampliﬁed” for both
tests), and differences between irradiated and untreated
aliquots were tested for signiﬁcance by use of symmetry
x2 tests.
All 29 irradiated aliquots underwent a color change
from green to light brown, with a concomitant increase
in temperature, as did unused bottles of Scope (ﬁg. 1);
the three aliquots that were shipped but not irradiated
did not change color. Median DNA yields per aliquot
were signiﬁcantly less for irradiated aliquots than for
untreated aliquots, as measured by spectrophotometry
(5.9 mg vs. 12.3 mg; ), PicoGreen assay (3.9 mgPp .002
vs. 8.9 mg; ), and TaqMan assay (3.7 mg vs. 7.6Pp .01
mg; ) (table 1). (N.B.: The expected medianP ! .0005
yield for the whole specimen is twice that of an aliquot
[e.g., 15.2 mg/specimen, on the basis of the TaqMan
assay] and is similar to the median yield [16.6 mg/speci-
men] observed elsewhere from participants in a breast
cancer case-control study [Garcia-Closas et al. 2001].)
Irradiated aliquots had a slightly greater DNA purity,
as measured by the spectrophotometric ratio of 260:
280 nm, than untreated aliquots ( vs.untreatedp 1.67
; ).irradiatedp 1.74 Pp .07
The irradiated aliquots were more likely to have a
smaller maximum size of DNA fragments on integrity gels
than were untreated aliquots ( ) (table 1); irra-P ! .0005
diated aliquots (93.1%) were also more likely than un-
treated aliquots (3.5%) to have genomic DNA that did
not migrate into the gel ( ) and exhibited weakerP ! .0005
or no PCR ampliﬁcation of the 989-bp b-globin DNA
fragment (0% positive, 97%weak positive, and 3%neg-
ative), compared with the irradiated aliquots (93% posi-
tive, 7% weak positive, and 0% negative) ( )P ! .0005
(ﬁg. 2; table 1). All aliquots, irradiated or untreated, were
positive for ampliﬁcation of 268-bp and 536-bp b-globin
DNA fragments. (The ampliﬁcation of the 536-bp frag-
ment appeared to be more efﬁcient than for the other
fragments, which resulted in ratings of some ampliﬁed
products as “strong positive” by the test lab. “Positive”
and “strong positive” ratings were conservatively com-
bined. However, untreated aliquots were more likely to
be called “strong positive” than irradiated aliquots
[ ].)P ! .0005
Measurement failure was nonsigniﬁcantly more likely
to occur in irradiated aliquots than untreated aliquots for
each STR that was considered individually (ﬁg. 3). In a
linear regression model of failure rates versus size of test
STR (range 112–359 bp) and irradiation status, fragment
size ( ), irradiation status ( ), and the in-P ! .0005 Pp .08
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teraction of fragment size and irradiation status (Pp
) were associated with increasedmeasurement failure..01
There were no signiﬁcant differences in detection of SNPs
from irradiated and untreated aliquots.
In our study using paired aliquots, one irradiated by
E-beam irradiation and the other untreated, we demon-
strated that there was a signiﬁcant decrease in DNA yield
following irradiation. A decrease in the yield for extracted
DNA in irradiated aliquots may be due, in part, to DNA
cross-linking and subsequent degradation following
strand damage. This is consistent with an observed DNA
fraction that did not migrate in the genomic integrity gels
in the irradiated aliquots only (data not shown). There
was also evidence (e.g., reduced ampliﬁcation of the 989-
bp b-globin fragment, shorter maximum DNA fragment
size, and reduced efﬁciency for longer STRs) that the
irradiation caused cleavage of DNA strands. Whether
DNA cross-linking and cleavage are the result of direct
absorption of E-beam energy by DNA or the generation
of heat by the E-beam treatment remains an unanswered
question.
Additional studies are needed to evaluate the impact of
E-beam irradiation on other biospecimens. A recent study
of E-beam–irradiated dried blood spots made from um-
bilical cord blood found that b-globin fragments (300–
1300 bp)—but notwhole genomes—were ampliﬁable (Dr.
Joanne Mei, Centers for Disease Control and Prevention,
Department of Health and Human Services; personal
communication).
We conclude that E-beam irradiation reduces the yields
and quality of DNA extracted from buccal-cell collec-
tions. Although there might be sufﬁcient DNA integrity
for small fragment ampliﬁcations for at least some ge-
netic analyses, we infer from our data that ampliﬁcation
of longer DNA targets and whole genomes may be com-
promised. One limitation to our study is that we did not
incorporate a quantitative PCR method to more accu-
rately measure losses in ampliﬁable DNA, and, thus, we
may have underestimated the impact of the irradiation
on genomic DNA. We emphasize that this was a pilot
study to measure the effects of E-beam irradiation on
buccal-cell genomic DNA, with a controlled exposure.
Further studies of buccal-cell specimens sent through the
U.S. Mail are now planned to evaluate the true E-beam
exposure and the impact those exposures on the genomic
DNA. The change in mouthwash color, which could oc-
cur prior to its use during the shipping of the mouthwash
to participants if E-beam sterilization becomes more
widely used, could negatively impact subject compliance
because of the color change and possible changes in taste.
The toxicity of the irradiated mouthwash is also uncer-
tain. These issues warrant consideration for future im-
plementation of this collection method.
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